Editas Medicine (EDIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | EDIT | MXCT | FULC | ||
| Company | Editas Medicine | Maxcyte Inc | Fulcrum Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 4.66 | 3.75 | 6.13 | ||
| High | 4.66 | 3.77 | 6.24 | ||
| Low | 4.48 | 3.58 | 5.92 | ||
| Last | 4.59 | 3.68 | 6.19 | ||
| Change | -0.07 | -0.08 | +0.04 | ||
| % Change | -1.50% | -2.13% | +0.57% | ||
| Volume | 1,288,711 | 709,874 | 649,149 | ||
| 20-Day Average Volume | 2,543,933 | 708,458 | 1,212,045 | ||
| Previous Close | 4.66 | 3.76 | 6.16 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 5.05 | 4.34 | 6.87 | ||
| 20-Day Raw Stochastic | 7.63% | 5.36% | 16.94% | ||
| 20-Day Relative Strength | 38.30% | 35.47% | 38.88% | ||
| Weighted Alpha | -63.97 | -30.57 | +25.89 | ||
| Today's Opinion | 100% Sell | 16% Sell | 56% Sell | ||
| Previous Opinion | 100% Sell | 8% Sell | 56% Sell | ||
| Last Month's Opinion | 88% Sell | 40% Buy | 32% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.27% since 06/27/24 | -8.25% since 06/27/24 | -1.43% since 06/27/24 | ||
| Low | 4.45 on 07/02/24 | 3.58 on 07/05/24 | 5.92 on 07/05/24 | ||
| High | 4.86 on 07/01/24 | 4.05 on 06/28/24 | 6.43 on 06/28/24 | ||
| 1-Month | |||||
| %Chg | -18.12% since 06/05/24 | -20.04% since 06/05/24 | -28.44% since 06/05/24 | ||
| Low | 4.45 on 07/02/24 | 3.58 on 07/05/24 | 5.68 on 06/26/24 | ||
| High | 6.22 on 06/12/24 | 5.26 on 06/11/24 | 8.69 on 06/06/24 | ||
| 3-Month | |||||
| %Chg | -31.77% since 04/05/24 | -11.57% since 04/05/24 | -27.35% since 04/05/24 | ||
| Low | 4.45 on 07/02/24 | 3.57 on 04/30/24 | 5.68 on 06/26/24 | ||
| High | 7.03 on 04/09/24 | 5.26 on 06/11/24 | 8.76 on 05/15/24 | ||
| 6-Month | |||||
| %Chg | -49.56% since 01/05/24 | -20.22% since 01/05/24 | -17.80% since 01/05/24 | ||
| Low | 4.45 on 07/02/24 | 3.57 on 04/30/24 | 5.68 on 06/26/24 | ||
| High | 11.58 on 02/28/24 | 5.55 on 01/12/24 | 13.70 on 03/06/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 383,229 | 392,529 | 382,558 | ||
| Shares Outstanding, K | 82,238 | 104,396 | 62,154 | ||
| Annual Sales | 78,120,000 | 41,290,000 | 2,810,000 | ||
| Annual Net Income | -153,220,000 | -37,920,000 | -97,340,000 | ||
| Last Quarter Sales | 1,140,000 | 11,340,000 | 870,000 | ||
| Last Quarter Net Income | -61,950,000 | -9,530,000 | -24,760,000 | ||
| 60-Month Beta | 2.01 | 1.41 | 2.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.76 on 05/08/24 | -0.09 on 05/07/24 | -0.43 on 05/13/24 | ||
| Latest Earnings Date | 08/07/24 | 08/14/24 | 08/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||